Better Coronavirus Stock: Abbott Labs vs. Moderna [The Motley Fool]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: The Motley Fool
There are multiple fronts and multiple players in the battle against novel coronavirus disease COVID-9. Some companies have developed diagnostic tests that help identify if individuals have COVID-9 or have antibodies to the virus that causes it. Others are developing antiviral drugs to treat COVID-9. And still others hope for success with their experimental vaccines to protect against infection by the novel coronavirus.Abbott Laboraties(NYSE:ABTModernaNASDAQ:MRNAImage source: Getty Images.The case for Abbott LabsOne of the chief complaints about COVID-9 diagnostics tests has been that they take too long for results to be available. Abbott Labs addressed this issue quite effectively by gaining emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) in late March fora new test that can provide a positive result within five minutesAnother key challenge has been in testing to determine if a person has antibodies to the novel coronavirus, which would indicate tha
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Home Blood Testing Devices Market to Grow by USD 2.96 Billion from 2024-2028, Driven by Disease Outbreaks, AI's Impact on the Market Landscape - Technavio Report [Yahoo! Finance]Yahoo! Finance
- Functional Powder Drink Concentrates Market to Grow by USD 903.7 Million (2024-2028) Driven by Rising Health Awareness, AI's Impact- Technavio Report [Yahoo! Finance]Yahoo! Finance
- Krabbe Disease Treatment Markets, Companies, and Growth Opportunities 2024-2030 - Advancements in Gene Therapy Expand Addressable Market [Yahoo! Finance]Yahoo! Finance
- Respiratory Diagnostics Market Report 2024-2030: A $9.8 Billion Opportunity - Surge in Demand for POC and Rapid Testing Solutions Generate New Business Opportunities [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change [Seeking Alpha]Seeking Alpha
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- 9/4/24 - Form 4
- ABT's page on the SEC website